Building Integrated Testing Programs for Infectious Diseases.

Autor:	Alemnji G; Office of the Global AIDS Coordinator and Health Diplomacy, US Department of State, Washington, District of Columbia, USA.; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Mosha F; Regional Office for Africa, World Health Organization, Harare, Zimbabwe., Maggiore P; Laboratory Services, Clinton Health Access Initiative, Boston, Massachusetts, USA., Alexander H; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Ndlovu N; Science Unit, African Society for Laboratory medicine, Johannesburg, South Africa., Kebede Y; Division of Laboratory Systems, Africa Centers for Disease Control and Prevention, Addis Ababa, Ethiopia., Tiam A; Technical Strategy and Innovation Department, Elizabeth Glaser Pediatrics AIDS Foundation, Washington, District of Columbia, USA., Albert H; Access Department, Foundation for Innovative New Diagnostics, Cape Town, South Africa., Edgil D; Supply Chain for Health Division, United States Agency for International Development, Washington, District of Columbia, USA., de Lussigny S; Program Division, Unitaid, Geneva, Switzerland., Peter T; Laboratory Services, Clinton Health Access Initiative, Boston, Massachusetts, USA.
Jazyk:	angličtina
Zdroj:	The Journal of infectious diseases [J Infect Dis] 2023 Nov 11; Vol. 228 (10), pp. 1314-1317.
DOI:	10.1093/infdis/jiad103
Abstrakt:	In the past 2 decades, testing services for diseases such as human immunodeficiency virus (HIV), tuberculosis, and malaria have expanded dramatically. Investments in testing capacity and supportive health systems have often been disease specific, resulting in siloed testing programs with suboptimal capacity, reduced efficiency, and limited ability to introduce additional tests or respond to new outbreaks. Emergency demand for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing overcame these silos and demonstrated the feasibility of integrated testing. Moving forward, an integrated public laboratory infrastructure that services multiple diseases, including SARS-CoV-2, influenza, HIV, tuberculosis, hepatitis, malaria, sexually transmitted diseases, and other infections, will help improve universal healthcare delivery and pandemic preparedness. However, integrated testing faces many barriers including poorly aligned health systems, funding, and policies. Strategies to overcome these include greater implementation of policies that support multidisease testing and treatment systems, diagnostic network optimization, bundled test procurement, and more rapid spread of innovation and best practices across disease programs. Competing Interests: Potential conflicts of interest. The authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. (Published by Oxford University Press on behalf of Infectious Diseases Society of America 2023.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu